1. Home
  2. KRNT vs ESPR Comparison

KRNT vs ESPR Comparison

Compare KRNT & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kornit Digital Ltd.

KRNT

Kornit Digital Ltd.

HOLD

Current Price

$14.77

Market Cap

668.4M

Sector

Industrials

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$2.66

Market Cap

731.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRNT
ESPR
Founded
2002
2008
Country
Israel
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
668.4M
731.9M
IPO Year
2014
2013

Fundamental Metrics

Financial Performance
Metric
KRNT
ESPR
Price
$14.77
$2.66
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$19.75
$7.60
AVG Volume (30 Days)
345.8K
5.2M
Earning Date
05-13-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.71
EPS
N/A
N/A
Revenue
N/A
$403,135,000.00
Revenue This Year
$4.52
$2.92
Revenue Next Year
$7.84
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
21.31
52 Week Low
$11.93
$0.73
52 Week High
$23.48
$4.18

Technical Indicators

Market Signals
Indicator
KRNT
ESPR
Relative Strength Index (RSI) 50.99 43.81
Support Level $14.08 $2.37
Resistance Level $15.15 $3.02
Average True Range (ATR) 0.55 0.19
MACD 0.03 0.03
Stochastic Oscillator 60.00 47.02

Price Performance

Historical Comparison
KRNT
ESPR

About KRNT Kornit Digital Ltd.

Kornit Digital Ltd develops, designs and markets digital printing solutions for the world-wide printed textile industry. The company focuses on its DTG and DTF segments of the printed textile industry. Its solutions include digital printing systems, ink and other consumables, associated software and value-added services that allow for large-scale printing of short runs of complex images and designs directly on finished garments and fabrics. It generates revenue from sales of systems, ink and other consumables and service including software subscriptions The company geographically operates in U.S., EMEA, Asia Pacific and other countries. It derives maximum revenue from U.S.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

Share on Social Networks: